Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer (Q28236320)

8

0 references

Gabriella Ferrandina

7

0 references

Marisa Mariani

2

0 references

Gian Franco Zannoni

5

0 references

Cristiano Ferlini

object named as

Cristiano Ferlini

10

0 references

Valerio Gaetano Vellone

object named as

Valerio Vellone

6

0 references

author name string

Marta De Donato

1

0 references

Lella Petrella

3

0 references

Enrica Martinelli

Journal of Cellular Physiology

4

0 references

language of work or name

English

0 references

publication date

March 2012

0 references

published in

0 references

volume

227

0 references

issue

3

0 references

page(s)

1034-41

0 references

cites work

The dynamic instability of microtubules is required for aggresome formation in oligodendroglial cells after proteolytic stress

1 reference

Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation

21 January 2018

1 reference

Cardiac progenitor cell cycling stimulated by pim-1 kinase

21 January 2018

1 reference

Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.

21 January 2018

1 reference

GBP1 overexpression is associated with a paclitaxel resistance phenotype

21 January 2018

1 reference

The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance.

21 January 2018

1 reference

Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77

21 January 2018

1 reference

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

21 January 2018

1 reference

Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel

21 January 2018

1 reference

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

21 January 2018

1 reference

Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer

21 January 2018

1 reference

Src kinases as therapeutic targets for cancer

21 January 2018

1 reference

Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors

21 January 2018

1 reference

betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer

21 January 2018

1 reference

Molecular mechanisms of patupilone resistance

21 January 2018

1 reference

From plasma membrane to cytoskeleton: a novel function for semaphorin 6A.

21 January 2018

1 reference

Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region

21 January 2018

1 reference

HuR regulates beta-tubulin isotype expression in ovarian cancer

21 January 2018

1 reference

Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?

21 January 2018

1 reference

Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10

21 January 2018

1 reference

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

21 January 2018

1 reference

release_bwtynnbr5zgtnhfjepp5x6vjjy

21 January 2018

Identifiers

DOI

10.1002/JCP.22813

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bwtynnbr5zgtnhfjepp5x6vjjy